CEREBROLYSIN

Last updated: January 6, 2025

For informational purposes only. Not medical advice. Always consult a healthcare professional.

Tried CEREBROLYSIN? Be part of the collective knowledge. Share your experience - your insights help others on their journey.

What Is CEREBROLYSIN?

PeptideNootropic

Cerebrolysin is a mixture of low-molecular-weight neuropeptides and amino acids derived from porcine brain tissue. It has neurotrophic effects similar to BDNF and NGF, and is used clinically for stroke recovery, dementia, and traumatic brain injury.

This is a peptide. Most peptides are research chemicals requiring reconstitution and subcutaneous injection. Purity and storage conditions matter.

Quick Verdict

We hesitated to call any nootropic “established neurological medicine.” Cerebrolysin earned it. It is used in hospitals across Europe and Asia for stroke, traumatic brain injury, and dementia. The clinical trials involve substantial patient populations. This is not a compound people order from research chemical vendors and experiment with at home, or at least it should not be. Sentiment is 78/100 across 6 tracked studies.

Evidence Quality

  • Human trials: Strong (clinical trials for stroke, TBI, and vascular dementia)
  • Animal evidence: Strong
  • Community reports: Moderate (limited self-experimentation due to IV/IM requirement and cost)
  • Key uncertainty: The exact active components within this porcine brain-derived peptide mixture have not been fully characterized, which complicates regulatory approval in the US.

What the Research Shows

Research shows cerebrolysin demonstrates neuropeptide properties showing promise for brain injury recovery, particularly in moderate to severe stroke patients when combined with neurorehabilitation. A meta-analysis examined cerebrolysin’s effects on subarachnoid hemorrhage patients, demonstrating positive outcomes. Reviews confirm promise in improving cognition in Alzheimer’s and vascular dementia. The compound requires intravenous or intramuscular injection, typically in a clinical setting. Treatment protocols in research involve daily injections over 10-20 day courses.

Who Should Be Cautious

People with epilepsy should avoid cerebrolysin due to seizure threshold concerns. Those with severe renal impairment need dose adjustment. Allergies to porcine-derived products are a contraindication.

What This Page Cannot Tell You

Why the FDA has not approved cerebrolysin despite extensive international clinical data is a regulatory question, not a scientific one. The undefined exact composition of a biological mixture makes it difficult to standardize by FDA criteria.

What Experts Say

Adderall, modafinil, or cerebrolysin? How many of the top people are on one or a combo?' (positioning it as a cognitive enhancer).

D
Dr. Abud Bakri Physician, MD

Reply to Bryan Johnson with Cerebrolysin dosing/protocol advice, IM injection details, and benefits (often paired with peptides).

D
Dr. Neil Paulvin Longevity Physician, MD

Links Eliezer Masliah research fraud investigation to broader questions around Cerebrolysin promotion and efficacy.

D
Dan Elton Scientist/researcher (Metascience founder, Foresight Institute fellow)

Quotes sourced from public posts on X or contributed exclusively to Dopamine Club. Views expressed are those of the original authors.

CEREBROLYSIN Research & Studies

01 Cerebrolysin for acute ischaemic stroke

Assessment of benefits and harms of cerebrolysin for treating acute ischemic stroke, finding little to no effect on death rates and serious adverse events.

View Study (PubMed)
02 Cerebrolysin: a multi-target drug for recovery after stroke

Neuropeptide drug showing promise for brain injury recovery, particularly in moderate to severe stroke patients when combined with neurorehabilitation.

View Study (PubMed)
03 Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes

Literature review examining cerebrolysin's potential in treating strokes, neurodegenerative disorders, and brain injuries, noting mixed clinical results.

View Study (PubMed)
04 Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis

Meta-analysis examining cerebrolysin's effects on subarachnoid hemorrhage patients, demonstrating positive impact on reducing mortality rates.

View Study (PubMed)
05 Cerebrolysin: a review of its use in dementia

Review of pig-brain-derived peptide medication showing promise in improving cognition in Alzheimer's and vascular dementia.

View Study (PubMed)
06 Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

Randomized controlled trial showing cerebrolysin significantly improved cognitive function and clinical outcomes in vascular dementia patients over 24 weeks.

View Study (ScienceDirect)

CEREBROLYSIN User Reviews & Experiences

78% Positive

Sentiment score computed from aggregated public user reports, forums, and community discussions. Not a clinical measure.

Users with neurological conditions and biohackers alike report significant cognitive improvements. Bryan Johnson's adoption has increased interest among longevity enthusiasts.

CEREBROLYSIN Benefits, Dosage & Side Effects

Effects
  • Cognitive Enhancement: Improved memory, focus, and mental clarity.
  • Neuroprotection: Protects neurons from damage and promotes survival.
  • Neuroplasticity: Enhances brain plasticity and learning capacity.
  • Mood Improvement: Many users report elevated mood and reduced brain fog.
Effectiveness
  • Clinical Validation: Extensively studied in medical settings.
  • Fast Acting: Many users notice effects within days of starting.
  • Cumulative Benefits: Improvements often persist after treatment course.
Dosage & Administration
  • Clinical Range: 5-30ml IV or IM daily for 10-30 days.
  • Biohacker Protocols: Often 5ml IM daily for 10-20 days.
  • Cycling: Usually administered in courses with breaks between.
Side Effects
  • Injection Site Reactions: Local discomfort or bruising.
  • Headaches: Some users experience transient headaches.
  • Dizziness: Occasionally reported, usually mild.
  • Generally Well Tolerated: Serious adverse events are rare.
Availability & Sourcing
  • Prescription in Europe: Available by prescription in many countries.
  • Not FDA Approved: Not available by prescription in the US.
  • International Pharmacies: Can be sourced from overseas.
  • Cost Consideration: Can be expensive, especially branded versions.

Related Compounds

Community Reviews

Share your experience with CEREBROLYSIN and help others make informed decisions.

Write a Review

Sign in to leave a review

Recent Reviews

Loading reviews...